Company Overview
Snapshot
Founded in August 2012 by Nir Shvalb, Momentis Surgical operates with 51–200 employees. The company has raised a total of $128.45M across 7 funding rounds from 7 investors. In November 2024, Momentis Surgical received FDA 510(k) clearance for its second-generation Anovo robotic platform, which introduces haptic feedback and dual-mode articulation.
Business overview
Momentis Surgical is dedicated to transforming robot-assisted surgery through its proprietary technology. The company's Anovo Surgical System features humanoid-shaped miniature robotic arms designed for high dexterity, superhuman flexibility, and 360-degree articulation, enabling exceptional access and maneuverability. This system is intended to assist in the accurate control of the Anovo Arms during single-site, natural orifice laparoscopic-assisted transvaginal benign surgical procedures. Momentis Surgical serves the healthcare industry, specifically targeting hospitals and ambulatory surgery centers with a cost-effective and smaller-footprint robotic system compared to conventional alternatives. The company operates within the Health Tech & Life Sciences sector, focusing on medical devices, medical treatment, and therapeutics, with a core technology in machinery and robotics.
Strategic signal
Momentis Surgical received FDA 510(k) clearance for its second-generation Anovo robotic platform in November 2024, integrating haptic feedback and dual-mode articulation. This development is significant as it enhances the precision and control offered by the Anovo system, potentially broadening its applicability and improving surgical outcomes. For investors, this signals continued product innovation and regulatory validation, reinforcing the company's competitive position in the rapidly evolving robotic-assisted surgery market.
Log in to access full profile ›Company Intelligence Q&A
- What was a significant recent regulatory achievement for Momentis Surgical?
- In November 2024, Momentis Surgical received FDA 510(k) clearance for its second-generation Anovo robotic platform, which introduces haptic feedback and dual-mode articulation.
- What was a key expansion for Momentis Surgical in October 2024?
- In October 2024, Momentis Surgical expanded into the general surgery market with FDA 510(k) clearance for its Anovo robotic system.
- What was the outcome of the SPAC deal discussions for Momentis Surgical in March 2022?
- In March 2022, MedTech Acquisition Corporation and Memic Innovative Surgery Ltd. (now Momentis Surgical) mutually agreed to terminate their business combination.
- When did Momentis Surgical rebrand from Memic Innovative Surgery?
- In July 2022, Memic Innovative Surgery announced its rebrand to Momentis Surgical to reflect a corporate transformation.
- What was a notable operational change for Momentis Surgical in May 2023?
- In May 2023, Momentis Surgical underwent a team reduction, cutting 60% of its staff.